➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Boehringer Ingelheim
AstraZeneca
Express Scripts
Moodys

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Ergotamine Derivative Drug Class List


Email this page to a colleague

« Back to Dashboard

Drugs in Drug Class: Ergotamine Derivative

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz CAFERGOT caffeine; ergotamine tartrate TABLET;ORAL 084294-001 Approved Prior to Jan 1, 1982 AA RX No Yes   Get Started Free   Get Started Free   Get Started Free
Bausch D.H.E. 45 dihydroergotamine mesylate INJECTABLE;INJECTION 005929-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Custopharm Inc DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate SPRAY, METERED;NASAL 211393-001 Feb 28, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
AstraZeneca
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.